|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/12 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Number of the document | 2805726 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14181565.4 |
| Date of filing the European patent application | 2009-09-10 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-02 |
| (46) | Date of publication of the claims translation | 2018-08-10 |
| (30) | Number | Date | Country code |
| 191725 P | 2008-09-11 | US | |
| 209689 P | 2009-03-10 | US |
| (72) |
Ku, Yiyin, US
Or, Yat, Sun, US
Wagaw, Sable, H., US
Engstrom, Ken, US
Grieme, Tim, US
Sheikh, Ahmad, US
Mei, Jianzhang, US
McDaniel, Keith, F., US
Chen, Hui-ju, US
Shanley, Jason, P., US
Kempf, Dale, J., US
Grampovnik, David, J., US
Gai, Yonghua, US
Sun, Ying, US
Liu, Dong, US
|
| (73) |
Enanta Pharmaceuticals, Inc.,
500 Arsenal Street, Watertown, MA 02472,
US
AbbVie Ireland Unlimited Company, 70 Sir John Rogerson`s Quay, Dublin 2, IE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Hepatito C serino proteazės makrocikliniai inhibitoriai |
| Macrocyclic hepatitis C serine protease inhibitors |
| Payment date | Validity (years) | Amount | |
| 2019-08-22 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-09-10 |